Skip to main content

Robert Coffey Archives

Coffey lands major NCI award to support colorectal cancer research

Jun. 8, 2017—Vanderbilt’s Robert Coffey Jr., M.D., has received an Outstanding Investigator Award from the National Cancer Institute (NCI) — more than $6.6 million over seven years — to support studies aimed at advancing the diagnosis and treatment of colorectal cancer (CRC), a leading cancer killer.

Read more


Glowing receptors help find and track cancerous growth

May. 18, 2017—Under the microscope, they sparkle like emeralds, these molecules that may hold a key to understanding — and stopping — cancerous growth.

Read more


Study takes 3-D perspective on colorectal cancer

Mar. 23, 2017—Despite dramatic recent advances in treatment, colorectal cancer killed more than 49,000 Americans last year, according to the National Cancer Institute, making it the second most lethal malignancy after cancers of the lung and bronchus.

Read more


‘Young Scientist’ showcases high schoolers’ research at Vanderbilt

Jun. 2, 2016—High school students performing advanced research at Vanderbilt have the opportunity to share their findings with the scientific community through a journal of their own.

Read more


Singer’s concert honors care received at Cancer Center

Mar. 24, 2016—A cancer patient’s gratitude toward his Vanderbilt-Ingram Cancer Center (VICC) physician led to a star-studded concert to benefit the Cancer Center.

Read more


Study explores less invasive way to monitor colorectal cancer

Feb. 18, 2016—Investigators at Vanderbilt University Medical Center have published research regarding an important feature of colorectal cancer (CRC) that could eventually lead to the development of non-invasive means of monitoring cancer progression. After lung cancer, CRC is the second-most lethal cancer in the United States.

Read more


Bad “traffic” linked to cancer

Sep. 3, 2015—Understanding how signaling molecules are transported within and out of the cell may help to uncover the causes of certain cancers.

Read more


Study sheds light on human gut’s ‘pacemaker’ cells

Jul. 30, 2015—The gut has its own built-in pacemakers, populations of specialized cells that control smooth muscle contraction in the stomach, small intestine and colon.

Read more


Protein’s role in spread of colon cancer studied

Apr. 3, 2014—One of the most formidable weapons in a cancer’s arsenal is the ability to spread to other organs.

Read more


$5.2M NIH grant bolsters colorectal cancer research

Aug. 15, 2013—Robert Coffey Jr., M.D., Ingram Professor of Cancer Research at Vanderbilt University, has received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to study the role of extracellular RNA (ex-RNA) in colorectal cancer.

Read more


VU study identifies new mechanism for cancer development

Jun. 6, 2013—Researchers at Vanderbilt University Medical Center led by a 32-year-old postdoctoral fellow have discovered a new mechanism for the development of cancer that is challenging conventional scientific wisdom.

Read more


VICC hosts cancer researchers during annual retreat

May. 23, 2013—The role of inflammation in gastrointestinal cancer development was a prominent theme among guest speakers during the Vanderbilt-Ingram Cancer Center annual retreat held at the Vanderbilt Student Life Center.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more